Physicochemical Characteristics of Transferon™ Batches
Emilio Medina-Rivero, Luis Vallejo-Castillo, Said Vázquez-Leyva, Gilberto Pérez-Sánchez, Liliana Favari, Marco Velasco-Velázquez, Sergio Estrada-Parra, Lenin Pavón, Sonia Mayra Pérez-Tapia, Emilio Medina-Rivero, Luis Vallejo-Castillo, Said Vázquez-Leyva, Gilberto Pérez-Sánchez, Liliana Favari, Marco Velasco-Velázquez, Sergio Estrada-Parra, Lenin Pavón, Sonia Mayra Pérez-Tapia
Abstract
Transferon, a biotherapeutic agent that has been used for the past 2 decades for diseases with an inflammatory component, has been approved by regulatory authorities in Mexico (COFEPRIS) for the treatment of patients with herpes infection. The active pharmaceutical ingredient (API) of Transferon is based on polydispersion of peptides that have been extracted from lysed human leukocytes by a dialysis process and a subsequent ultrafiltration step to select molecules below 10 kDa. To physicochemically characterize the drug product, we developed chromatographic methods and an SDS-PAGE approach to analyze the composition and the overall variability of Transferon. Reversed-phase chromatographic profiles of peptide populations demonstrated batch-to-batch consistency from 10 representative batches that harbored 4 primary peaks with a relative standard deviation (RSD) of less than 7%. Aminogram profiles exhibited 17 proteinogenic amino acids and showed that glycine was the most abundant amino acid, with a relative content of approximately 18%. Further, based on their electrophoretic migration, the peptide populations exhibited a molecular mass of about 10 kDa. Finally, we determined the Transferon fingerprint using a mass spectrometry tool. Because each batch was produced from independent pooled buffy coat samples from healthy donors, supplied by a local blood bank, our results support the consistency of the production of Transferon and reveal its peptide identity with regard to its physicochemical attributes.
Figures
References
- Salinas-Jazmin N., Estrada-Parra S., Becerril-Garcia M. A., et al. Herpes murine model as a biological assay to test dialyzable leukocyte extracts activity. Journal of Immunology Research. 2015;2015:9. doi: 10.1155/2015/146305.146305
- Medina-Rivero E., Merchand-Reyes G., Pavón L., et al. Batch-to-batch reproducibility of Transferon™ . Journal of Pharmaceutical and Biomedical Analysis. 2014;88:289–294. doi: 10.1016/j.jpba.2013.09.004.
- Berrón-Pérez R., Chávez-Sánchez R., Estrada-García I., et al. Indications, usage, and dosage of the transfer factor. Revista Alergia México. 2007;54(4):134–139.
- Viza D., Fudenberg H. H., Palareti A., Ablashi D., De Vinci C., Pizza G. Transfer factor: an overlooked potential for the prevention and treatment of infectious diseases. Folia Biologica. 2013;59(2):53–67.
- Krishnaveni M. A review on transfer factor an immune modulator. Drug Invention Today. 2013;5(2):153–156. doi: 10.1016/j.dit.2013.04.002.
- Ojeda M. O., Fernández-Ortega C., Rosaínz M. D. J. A. Dialyzable leukocyte extract suppresses the activity of essential transcription factors for HIV-1 gene expression in unstimulated MT-4 cells. Biochemical and Biophysical Research Communications. 2000;273(3):1099–1103. doi: 10.1006/bbrc.2000.3065.
- Navarro Cruz D., Serrano Miranda E., Orea S. E. P. M., Teran Ortiz L., Gomez Vera J., Flores Sandoval G. Transference factor in moderate and severeatopic dermatitis. Revista Alergia México. 1996;43(5):116–123.
- Pizza G., De Vinci C., Conte G. L., et al. Immunotherapy of metastatic kidney cancer. International Journal of Cancer. 2001;94(1):109–120. doi: 10.1002/ijc.1426.
- Pizza G., de Vinci C., Viza D. Immunotherapeutic approaches for renal cancer. Folia Biologica. 2002;48(5):167–181.
- Lawrence H. S. The transfer in humans of delayed skin sensitivity to streptococcal M substance and to tuberculin with disrupted leucocytes. The Journal of Clinical Investigation. 1955;34(2):219–230. doi: 10.1172/jci103075.
- Rozzo S. J., Kirkpatrick C. H. Purification of transfer factors. Molecular Immunology. 1992;29(2):167–182. doi: 10.1016/0161-5890(92)90098-I.
- Feng X.-L., Liu Q.-T., Cao R.-B., et al. Characterization and immunomodulatory function comparison of various bursal-derived peptides isolated from the humoral central immune organ. Peptides. 2012;33(2):258–264. doi: 10.1016/j.peptides.2012.01.012.
- Merchand-Reyes G., Pavón L., Pérez-Sánchez G., et al. Swine dialyzable spleen extract as antiviral prophylaxis. Journal of Medicinal Food. 2015;18(11):1239–1246. doi: 10.1089/jmf.2014.0176.
- Zhou J., Kong C., Yuan Z., et al. Preparation, characterization, and determination of immunological activities of transfer factor specific to human sperm antigen. BioMed Research International. 2013;2013:7. doi: 10.1155/2013/126923.126923
- Li C., Huang L., Wang Y., Li X., Liang S., Zheng Y. Preparation and properties of the specific anti-influenza virus transfer factor. Head and Face Medicine. 2010;6(1, article 22) doi: 10.1186/1746-160x-6-22.
- Kirkpatrick C. H. Transfer factors: identification of conserved sequences in transfer factor molecules. Molecular Medicine. 2000;6(4):332–341.
- Agyei D., Danquah M. K. Industrial-scale manufacturing of pharmaceutical-grade bioactive peptides. Biotechnology Advances. 2011;29(3):272–277. doi: 10.1016/j.biotechadv.2011.01.001.
- Craik D. J., Fairlie D. P., Liras S., Price D. The future of peptide-based drugs. Chemical Biology and Drug Design. 2013;81(1):136–147. doi: 10.1111/cbdd.12055.
- Baram P., Mosko M. M. Chromatography of the human tuberculin delayed-type hypersensitivity transfer factor. Journal of Allergy. 1962;33(6):498–506. doi: 10.1016/0021-8707(62)90017-5.
- Gottlieb A. A., Foster L. G., Waldman S. R., Lopez M. What is transfer factor? The Lancet. 1973;302(7833):822–823. doi: 10.1016/s0140-6736(73)90861-1.
- ICH Steering Committee. Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients. Geneva, Switzerland: ICH; 2000.
- ICH Steering Committee. Specifications: Test Procedures and Acceptance Criteria for Biotechnological/Biological Products Q6B. ICH; 1999.
- Nirenberg U. Reversed-phase HPLC: analytical procedure. In: Dun B., Pennington M., editors. Peptide Analysis Protocols. Vol. 36. New Jersey, NJ, USA: Humana Press; 1996. pp. 23–37.
- Alaiz M., Navarro J. L., Girón J., Vioque E. Amino acid analysis by high-performance liquid chromatography after derivatization with diethyl ethoxymethylenemalonate. Journal of Chromatography A. 1992;591(1-2):181–186. doi: 10.1016/0021-9673(92)80236-n.
- Clynen E., Baggerman G., Husson S. J., Landuyt B., Schoofs L. Peptidomics in drug research. Expert Opinion on Drug Discovery. 2008;3(4):425–440. doi: 10.1517/17460441.3.4.425.
- Borkowsky W., Suleski P., Bhardwaj N., Lawrence H. S. Antigen-specific activity of murine leukocyte dialysates containing transfer factor on human leukocytes in the leukocyte migration inhibition (LMI) assay. The Journal of Immunology. 1981;126(1):80–82.
- Comisión permanente de la Farmacopea de los Estados Unidos Mexicanos. MGA-0316. Determinación de endotoxina bacteriana. Farmacopea de los Estados Unidos Mexicanos MGA-0316, vol. 1, México, 2011.
- Comisión Permanente de la Farmacopea de los Estados Unidos Mexicanos. MGA-0571. Determinación de contenido bacteriano. Farmacopea de los Estados Unidos Mexicanos MGA-0571. 2011;1
- Thermo Fisher Scientific. Pierce BCA Protein Assay Kit. Hanover Park, Ill, USA: Thermo Fisher Scientific; 2013.
- Waters. Acquity UPLC H-Class and H-Class bio Amino Acid Analysis. 2012.
- Hernandez M. E., Mendieta D., Pérez-Tapia M., et al. Effect of selective serotonin reuptake inhibitors and immunomodulator on cytokines levels: an alternative therapy for patients with major depressive disorder. Clinical and Developmental Immunology. 2013;2013:11. doi: 10.1155/2013/267871.267871
- Jones C. J., Beni S., Limtiaco J. F. K., Langeslay D. J., Larive C. K. Heparin characterization: challenges and solutions. Annual Review of Analytical Chemistry. 2011;4:439–465. doi: 10.1146/annurev-anchem-061010-113911.
- Denis A., Brambati N., Dessauvages B., et al. Molecular weight determination of hydrolyzed collagens. Food Hydrocolloids. 2008;22(6):989–994. doi: 10.1016/j.foodhyd.2007.05.016.
Source: PubMed